Psychopharmacology for young children: clinical needs and research opportunities.

@article{Vitiello2001PsychopharmacologyFY,
  title={Psychopharmacology for young children: clinical needs and research opportunities.},
  author={B. Vitiello},
  journal={Pediatrics},
  year={2001},
  volume={108 4},
  pages={
          983-9
        }
}
In response to concerns about the increasing use of psychotropic medications in preschoolers, the National Institute of Mental Health and the Food and Drug Administration convened a workshop in October 2000 to examine the current state of knowledge regarding psychopharmacology for young children and discuss a variety of topics relevant to research in this age group, including safety, efficacy, investigational methods, and ethical aspects. The meeting gathered researchers, practitioners… Expand
Developing strategies for psychopharmacological studies in preschool children.
TLDR
The obstacles and special challenges-ethical, practical, scientific, and regulatory-faced by investigators who attempt to conduct psychopharmacological studies in preschoolers are identified. Expand
Ethical issues in child psychopharmacology research and practice: emphasis on preschoolers
TLDR
Some challenges facing mental health care providers involved in prescribing or researching the use of psychoactive drugs in preschoolers are reviewed, including those related to medical treatment and research with children. Expand
Pediatric psychopharmacology: A review of new developments and recent research
Advances in psychopharmacology have revolutionalized the management of emotional and behavioral disorders in children and adolescents. Recent developments in pediatric psychopharmacology and theExpand
Evidence-based psychopharmacology for children and adolescents
Purpose of review To provide an update of recent advances in child and adolescent psychopharmacology. Recent findings Changes in legislation in the United States and increased funding by the NationalExpand
Ethical considerations in psychopharmacological research involving children and adolescents
TLDR
Research on human subject issues relevant to child participation is a promising approach to improving ethical methods and procedures of pediatric psychopharmacology. Expand
Psychopharmacologic treatment of aggressive preschoolers: A chart review
  • J. Staller
  • Psychology, Medicine
  • Progress in Neuro-Psychopharmacology and Biological Psychiatry
  • 2007
TLDR
Medication was prescribed for a majority of the children with prominent aggression and atypical antipsychotics were prescribed with the greatest frequency, followed by stimulants and then alpha agonists--treatment response ratings indicated moderate to marked improved in a majorityof the preschoolers who received one or a combination of these medications. Expand
Psychotropic utilization and psychiatric presentation of hospitalized very young children.
TLDR
The aim of this study was to examine the prevalence and nature of psychotropics prescribed by child psychiatrists to very young children with severe functional impairment secondary to psychiatric pathology, and the clinical context in which these psychotropicics were prescribed. Expand
Psychopharmacology of conduct disorder: current progress and future directions
TLDR
Critical issues in the effectiveness of the evidence-based pharmacotherapy for CD are raised and future directions of the psychopharmacology of CD are examined. Expand
The impact of prescribed psychotropics on youth
TLDR
It is concluded that researchers should clarify child/adult differences for psychotropics, attend to the growth of "cosmetic" use of psychotropic use in children and adolescents, and address concerns about the diagnostic validity of mental illness in the current DSM classification system. Expand
Use of psychotropic agents in preschool children: associated symptoms, diagnoses, and health care services in a health maintenance organization.
TLDR
Most children receiving psychopharmacotherapy had substantial additional risk factors and were receiving psychosocial services for mental health or behavioral management, and such treatment was only infrequently received in this health plan. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 32 REFERENCES
Medication development and testing in children and adolescents. Current problems, future directions.
TLDR
Recommendations for possible solutions are presented, some of which are being implemented, and there is no substitute for pediatric psychopharmacological research. Expand
Controlled Trial of Methylphenidate in Preschool Children with Minimal Brain Dysfunction
TLDR
The intent of the study was to maintain, as nearly as possible, the requirements of proper short-term care on a clinical basis while, at the same time, collecting physical, behavioral, cognitive, and background data on the children undergoing treatment. Expand
Effects of methylphenidate on preschool children with ADHD: cognitive and behavioral functions.
TLDR
It is suggested that methylphenidate can be used to improve the functioning of preschool-age children with ADHD, in a manner similar to their school-age counterparts. Expand
Trends in the prescribing of psychotropic medications to preschoolers.
TLDR
Sizable increases in prevalence were noted between 1991 and 1995 across the 3 sites for clonidine, stimulants, and antidepressants, while neuroleptic use increased only slightly. Expand
Efficacy of methylphenidate among preschool children with developmental disabilities and ADHD.
TLDR
It is suggested that preschool children with developmental disabilities and ADHD respond to MPH at rates similar to those of school-age children with mental retardation and ADHD, however, this population appears to be especially susceptible to adverse drug side effects. Expand
Diagnosis of attention-deficit/hyperactivity disorder and use of psychotropic medication in very young children.
TLDR
To identify patterns of diagnosis and treatment of ADHD in very young children over time, a descriptive study of Michigan Medicaid claims data identified 223 children aged 3 years or younger diagnosed with ADHD and received markedly variable psychotropic medication regimens. Expand
Sertraline in children and adolescents with obsessive-compulsive disorder: a multicenter randomized controlled trial.
TLDR
Sertraline appears to be a safe and effective short-term treatment for children and adolescents with obsessive-compulsive disorder. Expand
The effects of methylphenidate on the interactions of preschool ADHD children with their mothers.
  • R. Barkley
  • Medicine
  • Journal of the American Academy of Child and Adolescent Psychiatry
  • 1988
TLDR
Attention deficit hyperactivity disordered children on high doses decreased their off-task and noncompliant behavior and significantly increased their rates of compliance as well as the length of sustained compliance with maternal commands. Expand
Increased methylphenidate usage for attention deficit disorder in the 1990s.
TLDR
The database findings presented serve to correct exaggerated media claims of a 6-fold expansion of methylphenidate treatment, although they do not clarify the issue of the appropriateness of this treatment. Expand
Fluvoxamine for children and adolescents with obsessive-compulsive disorder: a randomized, controlled, multicenter trial.
  • M. Riddle, E. Reeve, +8 authors J. Walkup
  • Psychology, Medicine
  • Journal of the American Academy of Child and Adolescent Psychiatry
  • 2001
TLDR
Fuvoxamine has a rapid onset of action and is well tolerated and efficacious for the short-term treatment of pediatric OCD. Expand
...
1
2
3
4
...